KomiPharm Ranks High in Search... Stock Price Down 2.31%
As of 1:30 PM on the 30th, Komipharm is trading at 12,700 KRW, down 2.31% from the previous day. This represents a 19.11% decline compared to October 6. Komipharm is known as a manufacturer of veterinary vaccines and disinfectants.
Today, foreigners are tentatively recorded as net sellers of 8,000 shares of Komipharm, while institutions are net sellers of 1,000 shares. Over the past five days, individual investors have net sold 112,749 shares, whereas foreigners and institutions have net bought 25,595 shares and 96,276 shares, respectively.
On October 27, Komipharm became a market topic with the headline, "New drug 'Kominox anticancer effect' confirmed?... Stock price rebounds."
Hot Picks Today
If They Fail Next Year, Bonus Drops to 97 Million Won... A Closer Look at Samsung Electronics DS Division’s 600M vs 460M vs 160M Performance Bonuses
- Opening a Bank Account in Korea Is Too Difficult..."Over 150,000 Won in Notarization Fees Just for a Child's Account and Debit Card" [Foreigner K-Finance Status]②
- [Local Election Interview] Chu Kyung-ho: "Daegu Needs a Competent Economic Expert... Attracting the Semiconductor Industry"
- Room Prices Soar from 60,000 to 760,000 Won and Sudden Cancellations: "We Won't Even Buy Water in Busan" — BTS Fans Outraged
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
※ Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
!["Please Help Us": How Much Do Those Bowing 90 Degrees These Days Actually Earn? [Data Pick]](https://cwcontent.asiae.co.kr/asiaresize/307/2026052010120870131_1779239528.png)
